Conditions: Hypertension, Hyperlipidemia
Allocation: RANDOMIZED | Intervention model: FACTORIAL
Enrollment: 168
Healthy volunteers: no

Brief summary:
This study aims to evaluate the efficacy and safety of the coadministration of valsartan (Diovan®) 160mg and rosuvastatin (Crestor®) 20mg in comparison to each component administered alone in patients with hypertension and hyperlipidemia.

Detailed description:

Arms:
arm 1: Both Valsartan 160mg and Rosuvastatin 20mg are administered daily by mouth once a day for 8 weeks. arm 2: Intervention : Drug : Both Valsartan 160mg and Rosuvastatin 20mg placebo are administered daily by p.o. once a day for 8 weeks. arm 3: Intervention : Drug : Both Valsartan 160mg placebo and Rosuvastatin 20mg are administered daily by p.o. once a day for 8 weeks. arm 4: Intervention : Drug : Both Valsartan 160mg placebo and Rosuvastatin 20mg placebo are administered daily by p.o. once a day for 8 weeks.

Interventions: intervention 1: Valsartan 160mg intervention 2: Rosuvastatin 20mg intervention 3: Valsartan 160mg placebo intervention 4: Rosuvastatin 20mg placebo
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None intervention 4: None

Protocol document: